Marcin Wegrecki

Dr. Marcin Wegrecki

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 February 2018 in Nature Structural & Molecular Biology
Verified
Journal Article
Open access
PDF file
CMConor McMahon
Conor McMahon
ABAlexander S. Baier
Alexander S. Baier
RPRoberta Pascolutti
Roberta Pascolutti
MWMarcin Wegrecki
Marcin Wegrecki
SZSanduo Zheng
Sanduo Zheng
AKAndrew C. Kruse
Andrew C. Kruse
Camelid single-domain antibody fragments (‘nanobodies’) provide the remarkable specificity of antibodies within a single 15-kDa immunoglobulin VHH domain. This unique feature has enabled applications ranging from use as biochemical tools to therapeutic agents. Nanobodies have emerged as especially useful tools in protein structural biology, facilitating studies of conformationally dynamic proteins such as G-protein-coupled receptors (GPCRs). Nearly all nanobodies available to date have been obtained by animal immunization, a bottleneck restricting many applications of this technology. To solve this problem, we report a fully in vitro platform for nanobody discovery based on yeast surface display. We provide a blueprint for identifying nanobodies, demonstrate the utility of the library by crystallizing a nanobody with its antigen, and most importantly, we utilize the platform to discover conformationally selective nanobodies to two distinct human GPCRs. To facilitate broad deployment of this platform, the library and associated protocols are freely available for nonprofit research.

1 May 2019 in Cell
Verified
Journal Article
Closed access
YDYang Du
Yang Du
NDNguyen Minh Duc
Nguyen Minh Duc
SRSøren G.F. Rasmussen
Søren G.F. Rasmussen
DHDaniel Hilger
Daniel Hilger
XKXavier Kubiak
Xavier Kubiak
KCKa Young Chung
Ka Young Chung

3 January 2020 in Science Immunology
Verified
Journal Article
Closed access
PDF file
SNSarah Nicolai
Sarah Nicolai
MWMarcin Wegrecki
Marcin Wegrecki
TCTan-Yun Cheng
Tan-Yun Cheng
EBElvire A. Bourgeois
Elvire A. Bourgeois
RCRachel N. Cotton
Rachel N. Cotton
AJAnnemieke de Jong
Annemieke de Jong
CD1a, an abundant lipid antigen–presenting molecule in human skin, mediates T cell responses to small contact allergens.

7 May 2021 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RCRachel N. Cotton
Rachel N. Cotton
MWMarcin Wegrecki
Marcin Wegrecki
TCTan-Yun Cheng
Tan-Yun Cheng
YCYi-Ling Chen
Yi-Ling Chen
NVNatacha Veerapen
Natacha Veerapen
DMD. Branch Moody
D. Branch Moody
We optimized lipidomics methods to broadly detect endogenous lipids bound to cellular CD1a proteins. Whereas membrane phospholipids dominate in cells, CD1a preferentially captured sphingolipids, especially a C42, doubly unsaturated sphingomyelin (42:2 SM). The natural 42:2 SM but not the more common 34:1 SM blocked CD1a tetramer binding to T cells in all human subjects tested. Thus, cellular CD1a selectively captures a particular endogenous lipid that broadly blocks its binding to TCRs. Crystal structures show that the short cellular SMs stabilized a triad of surface residues to remain flush with CD1a, but the longer lipids forced the phosphocholine group to ride above the display platform to hinder TCR approach. Whereas nearly all models emphasize antigen-mediated T cell activation, we propose that the CD1a system has intrinsic autoreactivity and is negatively regulated by natural endogenous inhibitors selectively bound in its cleft. Further, the detailed chemical structures of natural blockers could guide future design of therapeutic blockers of CD1a response.

5 July 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMarcin Wegrecki
Marcin Wegrecki
TOTonatiuh A. Ocampo
Tonatiuh A. Ocampo
SGSachith D. Gunasinghe
Sachith D. Gunasinghe
ABAnouk von Borstel
Anouk von Borstel
STShin Yi Tin
Shin Yi Tin
JRJamie Rossjohn
Jamie Rossjohn
CD1a is a monomorphic antigen-presenting molecule on dendritic cells that presents lipids to αβ T cells. Whether CD1a represents a ligand for other immune receptors remains unknown. Here we use CD1a tetramers to show that CD1a is a ligand for Vδ1+γδ T cells. Functional studies suggest that two γδ T cell receptors (TCRs) bound CD1a in a lipid-independent manner. The crystal structures of three Vγ4Vδ1 TCR-CD1a-lipid complexes reveal that the γδ TCR binds at the extreme far side and parallel to the long axis of the β-sheet floor of CD1a’s antigen-binding cleft. Here, the γδ TCR co-recognises the CD1a heavy chain and β2 microglobulin in a manner that is distinct from all other previously observed γδ TCR docking modalities. The ‘sideways’ and lipid antigen independent mode of autoreactive CD1a recognition induces TCR clustering on the cell surface and proximal T cell signalling as measured by CD3ζ phosphorylation. In contrast with the ‘end to end’ binding of αβ TCRs that typically contact carried antigens, autoreactive γδ TCRs support geometrically diverse approaches to CD1a, as well as antigen independent recognition.

4 January 2021 in Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
RCRachel N. Cotton
Rachel N. Cotton
TCTan-Yun Cheng
Tan-Yun Cheng
MWMarcin Wegrecki
Marcin Wegrecki
JNJerome Le Nours
Jerome Le Nours
DODennis P. Orgill
Dennis P. Orgill
DMD. Branch Moody
D. Branch Moody
CD1a-autoreactive T cells contribute to skin disease, but the identity of immunodominant self-lipid antigens and their mode of recognition are not yet solved. In most models, MHC and CD1 proteins serve as display platforms for smaller antigens. Here, we showed that CD1a tetramers without added antigen stained large T cell pools in every subject tested, accounting for approximately 1% of skin T cells. The mechanism of tetramer binding to T cells did not require any defined antigen. Binding occurred with approximately 100 lipid ligands carried by CD1a proteins, but could be tuned upward or downward with certain natural self-lipids. TCR recognition mapped to the outer A′ roof of CD1a at sites remote from the antigen exit portal, explaining how TCRs can bind CD1a rather than carried lipids. Thus, a major antigenic target of CD1a T cell autoreactivity in vivo is CD1a itself. Based on their high frequency and prevalence among donors, we conclude that CD1a-specific, lipid-independent T cells are a normal component of the human skin T cell repertoire. Bypassing the need to select antigens and effector molecules, CD1a tetramers represent a simple method to track such CD1a-specific T cells from tissues and in any clinical disease.